Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Mutation Burden”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03546452
What this trial is testing

A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC

Who this might be right for
Malignant HydrothoraxNSCLC
Shanghai Chest Hospital 50
Not applicableUnknownNCT04191252
What this trial is testing

Genetic Mutation in Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerNucleotide VariantCopy Number Variation+6 more
Lei Li 500
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Not applicableLooking for participantsNCT06792721
What this trial is testing

MEASUREMENT OF CIRCULATING MUTATION BURDEN

Who this might be right for
Breast CarcinomaGenetic Predisposition to CancerBRCA Mutation+2 more
Centre Francois Baclesse 30
Testing effectiveness (Phase 2)UnknownNCT04695470
What this trial is testing

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Aiping Zhou 70
Large-scale testing (Phase 3)Looking for participantsNCT05770102
What this trial is testing

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Who this might be right for
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more
Cancer Research UK 30
Post-approval studies (Phase 4)Study completedNCT04059887
What this trial is testing

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

Who this might be right for
Lung Neoplasm Malignant
Chonnam National University Hospital 100
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT03668119
What this trial is testing

Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

Who this might be right for
Pan Tumor
Bristol-Myers Squibb 212
Testing effectiveness (Phase 2)Study completedNCT04098068
What this trial is testing

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Who this might be right for
High Tumor Mutation BurdenHigh TMB (Tumor Mutation Burden)MSS (Microsatellite Stable)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableUnknownNCT05993052
What this trial is testing

Carotid Plaque Burden in Patients With Philadelphia Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
Sohag University 100
Not applicableUnknownNCT03683407
What this trial is testing

Effect of Chemotherapy on TMB in NSCLC

Who this might be right for
Chemotherapy EffectImmunotherapyTumor Mutation Burden+1 more
Baodong Qin 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197322
What this trial is testing

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Who this might be right for
Adenocarcinoma of the Colon
University College, London 88
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT05592626
What this trial is testing

A Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more
Marengo Therapeutics, Inc. 366
Not applicableUnknownNCT05750511
What this trial is testing

Multicenter Tissue Registry in Melanoma

Who this might be right for
Metastatic Melanoma
Dermatologic Cooperative Oncology Group 1,000
Not applicableUnknownNCT05058937
What this trial is testing

Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre

Who this might be right for
Solid TumorMetastatic Cancer
The Belgian Society of Medical Oncology 936
Testing effectiveness (Phase 2)UnknownNCT03638297
What this trial is testing

PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 29
Not applicableActive Not RecruitingNCT07407205
What this trial is testing

Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaOropharyngeal HPV Squamous Cell Carcinoma
Institute of Oncology Ljubljana 30
Very early researchWithdrawnNCT03671720
What this trial is testing

Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

Who this might be right for
Advanced CancerMetastatic Cancer
Capital Medical University
Next Page